Merck & Co., Inc. (MRK) 13D/13G Filings for PANDION THERAPEUTICS INC (PAND)

Merck & Co., Inc. 13D and 13G filings for PANDION THERAPEUTICS INC:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-03-04
06:06 am
Purchase
2021-02-24 13D PANDION THERAPEUTICS INC
PAND
Merck & Co. Inc.
MRK
11,776,706
39.990%
11,776,706increase
(New Position)
Filing